Type 1 Diabetes: The Stem Cell Solution for Beta Cell Regeneration

29 patients newly onset type 1 diabetes. They were given two infusions four weeks apart and they were able to show improvement in hemoglobin A1c and C peptide comparing to before the treatment or comparing to placebo group and another study using Wharton jelly msc and they were able to show that these MSC could even though they're called mesenchymal stem cells, Right? So they're supposed to be from mesoderm layer, but they can cross this germ layer and differentiate into insulin producing cells. So that's pretty cool, pretty exciting. What's fascinating is that some of these insulin producing cells were located in the liver and still even though they were in the liver, they were still able to normalize the hyperglycemia. Wharton's jelly MSCs can be differentiated better than bone marrow MSCs toward the mature beta cell type.